Purple Biotech Ltd
PPBT
$3.95
$0.102.55%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -23.55M | -1.09M | -410.00K | -663.00K | |
| Total Depreciation and Amortization | 53.00K | 47.00K | 40.00K | 49.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 20.54M | -91.00K | -640.00K | -1.34M | |
| Change in Net Operating Assets | 1.89M | -415.00K | -1.00M | -1.34M | |
| Cash from Operations | -1.07M | -1.54M | -2.01M | -3.30M | |
| Capital Expenditure | -3.00K | -2.00K | -- | -- | |
| Sale of Property, Plant, and Equipment | -6.00K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -95.00K | 109.00K | 38.00K | 72.00K | |
| Cash from Investing | -104.00K | 107.00K | 38.00K | 72.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -61.00K | -39.00K | -48.00K | -44.00K | |
| Issuance of Common Stock | 258.00K | 443.00K | 4.37M | 2.53M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 100.00K | -38.00K | -380.00K | -354.00K | |
| Cash from Financing | 297.00K | 366.00K | 3.94M | 2.13M | |
| Foreign Exchange rate Adjustments | -1.00K | 35.00K | 0.00 | 3.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -875.00K | -1.04M | 1.96M | -1.09M | |